What’s the quality of the evidence for using empagliflozin /SGLT2 inhibitors in patients without diabetes (HbA1C less than 5.9) for management of chronic kidney disease stage 3a or earlier and mild CAD. Can you speak to benefits versus risk of worsening osteoporosis, activation of fructose pathways and increased uric acid, and fungal infection
Dr. Attia, I wondered if you had any thoughts on TRF/Intermittent fasting for a student who takes stimulant medication for ADHD. If I do not take these medications with food, it can cause stress, abdominal discomfort, and nausea. I was interested in TRF/intermittent fasting alongside strength training and low-intensity aerobic exercise for fat loss, as I am 240lbs 6ft with 35% body fat. With TRF, I have tried adjusting the window to compensate, but stimulant medication timing with meals has made it challenging to study efficiently (throughout the day) in my graduate program. Any suggestions would be great. Thank you!